EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 105 filers reported holding EPIZYME INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $376,000 | -4.3% | 327,100 | +108.3% | 0.00% | – |
| Q4 2021 | $393,000 | -51.1% | 157,000 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $804,000 | -38.4% | 157,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,305,000 | -7.8% | 157,000 | -3.3% | 0.00% | 0.0% |
| Q1 2021 | $1,415,000 | -18.7% | 162,400 | +1.3% | 0.00% | 0.0% |
| Q4 2020 | $1,741,000 | -8.9% | 160,300 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,912,000 | -24.4% | 160,300 | +1.8% | 0.00% | -50.0% |
| Q2 2020 | $2,528,000 | +15.3% | 157,400 | +11.4% | 0.00% | 0.0% |
| Q1 2020 | $2,192,000 | -36.1% | 141,300 | +1.3% | 0.00% | -50.0% |
| Q4 2019 | $3,432,000 | +143.9% | 139,500 | +2.3% | 0.00% | +300.0% |
| Q3 2019 | $1,407,000 | -15.5% | 136,400 | +2.8% | 0.00% | -50.0% |
| Q2 2019 | $1,665,000 | +3.2% | 132,700 | +1.8% | 0.00% | 0.0% |
| Q1 2019 | $1,614,000 | +153.8% | 130,300 | +26.3% | 0.00% | +100.0% |
| Q4 2018 | $636,000 | -33.6% | 103,200 | +14.2% | 0.00% | 0.0% |
| Q3 2018 | $958,000 | -21.8% | 90,400 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,225,000 | -17.6% | 90,400 | +8.0% | 0.00% | -50.0% |
| Q1 2018 | $1,486,000 | +41.5% | 83,700 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $1,050,000 | -34.1% | 83,700 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $1,594,000 | +58.3% | 83,700 | +25.5% | 0.00% | +100.0% |
| Q2 2017 | $1,007,000 | -12.0% | 66,700 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,144,000 | +41.8% | 66,700 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $807,000 | +45.1% | 66,700 | +18.1% | 0.00% | 0.0% |
| Q3 2016 | $556,000 | -4.0% | 56,500 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $579,000 | -12.1% | 56,500 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $659,000 | +45.8% | 56,500 | +100.4% | 0.00% | 0.0% |
| Q4 2015 | $452,000 | +24.5% | 28,200 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $363,000 | -35.9% | 28,200 | +19.5% | 0.00% | 0.0% |
| Q2 2015 | $566,000 | +27.8% | 23,600 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $443,000 | +86.1% | 23,600 | +87.3% | 0.00% | 0.0% |
| Q4 2014 | $238,000 | -30.4% | 12,600 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $342,000 | +44.3% | 12,600 | +65.8% | 0.00% | 0.0% |
| Q2 2014 | $237,000 | +37.0% | 7,600 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $173,000 | +143.7% | 7,600 | +123.5% | 0.00% | – |
| Q4 2013 | $71,000 | – | 3,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |